{"id":3450,"date":"2026-01-29T16:09:04","date_gmt":"2026-01-29T15:09:04","guid":{"rendered":"https:\/\/www.amsvita.com\/en\/?p=3450"},"modified":"2026-03-28T16:11:29","modified_gmt":"2026-03-28T15:11:29","slug":"cell-viability-as-a-key-quality-factor-in-autologous-therapy","status":"publish","type":"post","link":"https:\/\/www.amsvita.com\/en\/news\/cell-viability-as-a-key-quality-factor-in-autologous-therapy\/","title":{"rendered":"Cell Viability as a Key Quality Factor in Autologous Therapy"},"content":{"rendered":"\n

What is cell viability and why it matters<\/strong><\/h2>\n\n\n\n

In the context of autologous regenerative therapies based on adipose tissue, cell viability<\/strong> refers to the presence of living, metabolically active, and proliferative cells within the harvested tissue or derived stromal vascular fraction (SVF). Adipose tissue contains a heterogeneous stromal compartment, including adipose-derived mesenchymal stem cells (ASCs), adipocyte progenitors, pericytes, endothelial progenitor cells, and other interrelated cell populations that contribute to tissue repair and regeneration. The ability of these cells to remain viable after harvesting and processing is central to the biological rationale of using autologous adipose tissue as a regenerative substrate.<\/p>\n\n\n\n

Mesenchymal stem cells present in adipose tissue are multipotent and can differentiate towards osteogenic, chondrogenic, myogenic, hepatogenic, and endothelial lineages in vitro and in vivo. They also exhibit antifibrotic and immunomodulatory characteristics and stimulate angiogenesis and revascularization of fat grafts. These properties underpin the use of micro-fragmented adipose tissue rich in SVF and ASCs as a promising approach for degenerative conditions, complex wounds, and aesthetic rejuvenation. Because these effects depend on living cells, maintaining high viability is a key quality factor for any autologous adipose-based therapy.<\/p>\n\n\n\n

In experimental evaluations of adipose tissue harvested with different cannulas, viability is inferred from metabolic activity measurements. For example, viable and metabolically active cells reduce resazurin in the Presto Blue assay, leading to an increase in absorbance over time. In adipose tissue harvested with microcannulas of 0.8 mm and 1 mm side port holes, as well as in SVF obtained by enzymatic digestion, an increase in absorbance over 72 hours indicates that the harvested tissue contains vital and proliferative cells. This functional readout links the concept of viability to measurable metabolic behavior.<\/p>\n\n\n\n

Clinically, autologous regenerative therapy (ART) is described as an innovative discipline that aims to regenerate injured tissues or stimulate their repair using the patient\u2019s own mesenchymal stem cells in a single medical procedure. The therapeutic rationale relies on the capacity of these autologous cells to respond to local signals and growth factors in the target environment. If the harvested cells are not viable, their ability to exert trophic, immunomodulatory, and differentiation-mediated effects is compromised. Thus, cell viability is not only a laboratory parameter but a critical determinant of the potential regenerative performance of autologous adipose-derived preparations.<\/p>\n\n\n\n

Methods to assess cell integrity<\/strong><\/h2>\n\n\n\n

Assessment of cell integrity<\/strong> and viability in autologous adipose-derived products is commonly based on metabolic assays and cell counting methods. In the comparison of harvesting and processing techniques for adipose tissue grafts, cell viability was evaluated using the Presto Blue assay, which exploits the reduction of resazurin by metabolically active cells. One hundred microliters of cell suspension were plated in 96-well plates, Presto Blue reagent was added, and absorbance at 570 nm was measured after incubation at 37 \u00b0C. The increase in absorbance over time reflects increased metabolic activity, indicating that the cells within the adipose tissue or SVF are viable and proliferating.<\/p>\n\n\n\n

For SVF obtained by enzymatic digestion, additional steps are used to characterize cell integrity. After collagenase digestion and centrifugation, the SVF pellet is resuspended in culture medium and cells are counted using Crystal violet staining to exclude anucleated cells. This approach allows discrimination between intact nucleated cells and cellular debris or enucleated elements, providing a more accurate estimate of viable cell numbers. The SVF is then plated at a defined density (10,000 cells\/cm\u00b2) for subsequent viability assessment with Presto Blue, linking structural integrity to functional metabolic capacity.<\/p>\n\n\n\n

Beyond bulk metabolic assays, characterization of stromal cells derived from adipose tissue harvested with SEFFI and micro-SEFFI cannulas has included evaluation of colony-forming unit\u2013fibroblast (CFU-F) formation and proliferative capacity. Freshly isolated ASCs (passage 0) grew in colonies visualized by methylene blue staining, and their proliferation was quantified using the Alamar Blue assay over five days. The ability to form CFU-Fs and to sustain proliferation over time indicates preserved cell integrity and stemness, complementing simple viability measurements.<\/p>\n\n\n\n

Mesenchymal differentiation assays further probe the functional integrity of ASCs. Cells isolated from adipose tissue harvested with cannulas of different side-port sizes (0.3 mm, 0.5 mm, and 0.8 mm) demonstrated the capacity to differentiate towards adipogenic, osteogenic, and chondrogenic lineages. This multipotent differentiation behavior confirms that the harvested cells are not only viable but also retain key mesenchymal characteristics. Together, metabolic assays, nucleated cell counts, CFU-F formation, proliferation curves, and differentiation assays provide a composite picture of cell integrity in autologous adipose-derived preparations.<\/p>\n\n\n\n

Factors influencing viability: harvest, handling, time<\/strong><\/h2>\n\n\n\n

The technique used to harvest adipose tissue is a major determinant of cell viability<\/strong>. In SEFFI (Superficial Enhanced Fluid Fat Injection) techniques, microcannulas with very small side port holes (0.8 mm and 1 mm) are used to select the cluster dimension during a guided superficial harvesting procedure. This approach allows the collection of micro-fragmented adipose tissue without the need for substantial post-harvest manipulation to thin the tissue. The study comparing cannulas showed that adipose tissue harvested with 0.8 mm and 1 mm side port holes, as well as tissue obtained via standard liposuction followed by enzymatic digestion, all contained viable and metabolically active cells, indicating that appropriately designed harvesting devices can preserve viability.<\/p>\n\n\n\n

Mechanical versus enzymatic processing also influences viability profiles. Enzymatic digestion with collagenase is particularly indicated for SVF isolation because it disrupts the extracellular matrix and the binding of adipocytes and other cells, yielding a cell suspension enriched in stromal elements. In the comparative study, SVF cells derived by enzymatic digestion showed lower absorbance at time 0, attributed to lower plating density compared with intact tissue, but after 72 hours their absorbance values were similar to those of tissue harvested with microcannulas. This suggests that, despite different initial conditions, both mechanically harvested tissue and enzymatically isolated SVF can support viable, proliferative cell populations when appropriately handled.<\/p>\n\n\n\n

Time after harvesting is another critical factor. In adipose tissue harvested with 0.8 mm and 1 mm side port cannulas, as well as in SVF obtained from liposuction tissue, cell viability assessed by Presto Blue increased between the initial time point (T0) and 72 hours (T72). The increase in absorbance over 72 hours indicates that cells not only survive but also proliferate during incubation, reflecting robust metabolic activity. The average absorbance was similar immediately after plating and after 72 hours for the two microcannulas, demonstrating that both systems equally harvest vital tissue and that viability is maintained over this time frame.<\/p>\n\n\n\n

The extent of mechanical manipulation after harvesting can negatively affect viability and stemness. The SEFFI technique is explicitly based on generating a highly fluid preparation of adipose tissue clusters during the harvesting step, avoiding further mechanical manipulation. A study cited in the description of this technique reported that tissue harvested without substantial manipulation showed higher viability and higher growth rate compared with tissue subjected to additional mechanical processing. This supports the concept that minimizing handling and processing steps helps preserve the viability and functional potential of adipose-derived cells in autologous therapies.<\/p>\n\n\n\n

Viability and regenerative efficacy<\/strong><\/h2>\n\n\n\n

The regenerative efficacy of autologous adipose-derived therapies is closely linked to the presence of viable stromal and mesenchymal cells within the graft. Micro-fragmented adipose tissue naturally rich in SVF and adipose-derived stem cells is considered a valuable approach for aesthetic rejuvenation, volumization, and skin regeneration, as well as for the treatment of degenerative diseases and complex wounds. The biological activities underlying these clinical effects, such as differentiation into multiple lineages, secretion of antifibrotic and immunomodulatory factors, and promotion of angiogenesis, require living, metabolically competent cells.<\/p>\n\n\n\n

In the context of osteoarthritis, autologous regenerative therapy using adipose-derived mesenchymal stem cells aims to regenerate cartilage, tendons, and bone or to stimulate their repair. ADSCs, particularly those found in the SVF of adipose tissue, are frequently used in the orthopedic field because of this intrinsic regenerative capacity. The clinical protocol described for intra-articular injection of fat micrograft in hip and knee osteoarthritis relies on harvesting superficial adipose tissue, isolating SVF, and injecting the micrograft in a single session. The assumption underlying this approach is that a sufficient number of viable mesenchymal and stromal cells are delivered to the joint to exert reparative and trophic effects.<\/p>\n\n\n\n

Experimental data support that microcannula-based harvesting can provide adipose tissue with a good amount of viable cells suitable for regenerative purposes. The comparison of harvesting and processing techniques demonstrated that guided harvesting with small side port microcannulas yields a comparable amount of viable cells to adipose tissue harvested with standard liposuction and processed with enzymatic digestion. The study concluded that minimally invasive harvesting with minimal manipulation can produce micro-fragmented adipose tissue that is a promising source for regenerative treatments, highlighting the direct connection between preserved viability and therapeutic potential.<\/p>\n\n\n\n

At the cellular level, ASCs isolated from adipose tissue harvested with SEFFI and micro-SEFFI cannulas retained the ability to form CFU-Fs and to differentiate into adipogenic, osteogenic, and chondrogenic lineages. These findings indicate that the harvesting approach preserves not only viability but also stemness, which is essential for regenerative efficacy. In clinical applications such as osteoarthritis treatment, the observed improvements in pain, range of motion, and stiffness after intra-articular injection of fat micrograft are consistent with the expected biological activities of viable mesenchymal and stromal cells delivered to the joint environment.<\/p>\n\n\n\n

Clinical importance and validation data<\/strong><\/h2>\n\n\n\n

Clinical data from osteoarthritis management illustrate the importance of viable autologous adipose-derived preparations. In a cohort of 250 patients with initial-stage degenerative hip or knee osteoarthritis, intra-articular injection of autologous fat micrograft obtained with a guided SEFFI-based device was performed in a standardized, single-session procedure. The donor site postoperative course was uneventful apart from minimal discomfort, and the technique was described as safe, standardized, easy, and effective. These outcomes are consistent with the use of a harvesting method designed to preserve tissue viability by minimizing trauma and manipulation.<\/p>\n\n\n\n

Clinically, patients demonstrated an average increase of 10 degrees in range of motion of the treated joint three months after treatment, along with a reduction in stiffness as reported by patients. Pain, assessed using the Visual Analog Scale (VAS), showed a progressive reduction at 3, 6, and 12 months, with the best scores at six months postoperatively. At one year, 85% of patients reported satisfaction with the treatment, with considerable improvement in pain and quality of life. These clinical results provide indirect validation that the autologous micro-fragmented adipose tissue used in this protocol maintains sufficient viability and functional capacity to exert meaningful therapeutic effects.<\/p>\n\n\n\n

Additional analysis of this cohort indicated that the best clinical results in terms of range of motion increase and stiffness reduction appeared around three months, while maximal pain reduction occurred between six and twelve months depending on the joint. Clinical improvement was more pronounced in younger patients with less severe osteoarthritis, although even patients with more advanced disease experienced pain reduction. These temporal patterns are compatible with a biologically mediated regenerative or reparative process driven by viable mesenchymal and stromal cells within the injected micrograft.<\/p>\n\n\n\n

From a broader regenerative medicine perspective, adipose tissue implantation has been used to improve skin trophism, accelerate closure of complex wounds or ulcers, and enhance skin appearance after radiotherapy damage. Micro-fragmented adipose tissue grafts rich in SVF and ADSCs are considered valuable for aesthetic rejuvenation treatments, providing both volumization and skin regeneration effects. These diverse clinical applications reinforce the concept that maintaining high viability and functional integrity of adipose-derived cells is central to the success of autologous therapies across different tissues and indications.<\/p>\n\n\n\n

Regulatory perspectives<\/strong><\/h2>\n\n\n\n

Regulatory considerations significantly influence the choice of methods used to obtain viable cells for autologous therapies. In the field of adipose-derived products, two main approaches to isolate SVF are described: enzymatic and mechanical. The enzymatic method, typically using collagenase, is particularly indicated for SVF isolation because it effectively disrupts the extracellular matrix and the binding of adipocytes and other cells, yielding a cell-rich suspension. However, enzymatic procedures are subject to regulatory restrictions, especially within the European Community, due to concerns related to the use of enzymes and the classification of the resulting product.<\/p>\n\n\n\n

In response to these regulatory constraints, alternative mechanical methods have been proposed to obtain regenerative adipose tissue without enzymatic digestion. Mechanical procedures can preserve cell viability while avoiding the regulatory issues associated with enzymes. The SEFFI technique exemplifies this approach by using microcannulas with small side port holes to harvest micro-fragmented adipose tissue in the superficial subcutaneous layer, thereby generating a highly fluid tissue preparation during the harvesting step and obviating the need for substantial post-harvest manipulation.<\/p>\n\n\n\n

The comparative study of harvesting and processing techniques demonstrated that adipose tissue harvested with guided microcannulas (0.8 mm and 1 mm side port holes) without any chemical or mechanical manipulation contains viable and proliferative cells, with viability comparable to that of tissue processed with enzymatic digestion. These findings support the regulatory attractiveness of minimally manipulated, mechanically harvested micro-fragmented adipose tissue as a promising option for regenerative therapy, aligning with frameworks that distinguish between minimal and substantial manipulation.<\/p>\n\n\n\n

Devices such as the guided SEFFI systems are described as CE-marked medical devices intended to perform autologous regenerative treatments in a safe, standardized, and effective way. They incorporate harvesting cannulas and guides designed to standardize the depth and plane of tissue collection, targeting superficial adipose tissue that has been shown to contain higher concentrations of mesenchymal and vascular stem cells. By integrating device design, harvesting technique, and minimal manipulation principles, these systems aim to meet regulatory expectations while preserving high cell viability, thereby supporting the clinical translation of autologous adipose-based therapies.<\/p>\n\n\n\n

Sources (Bibliography)<\/strong><\/h2>\n\n\n\n
    \n
  • Gennai A, Bovani B, Colli M, Melfa F, Piccolo D, Russo R, Roda B, Zattoni A, Reschiglian P, Zia S. Comparison of Harvesting and Processing Technique for Adipose Tissue Graft: Evaluation of Cell Viability. Int J Regener Med, 2021.<\/li>\n\n\n\n
  • Trentani P, Meredi E, Zarantonello P, Gennai A. Role of Autologous Micro-Fragmented Adipose Tissue in Osteoarthritis Treatment. J Pers Med, 2024.<\/li>\n\n\n\n
  • Characterization of Tissue and Stromal Cell for Facial Aging Treatment, 2020.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"

    What is cell viability and why it matters In the context of autologous regenerative therapies based on adipose tissue, cell viability refers to the presence of living, metabolically active, and proliferative cells within the harvested tissue or derived stromal vascular fraction (SVF). Adipose tissue contains a heterogeneous stromal compartment, including adipose-derived mesenchymal stem cells (ASCs), […]<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[59,8],"tags":[57,58],"_links":{"self":[{"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/posts\/3450"}],"collection":[{"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/comments?post=3450"}],"version-history":[{"count":1,"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/posts\/3450\/revisions"}],"predecessor-version":[{"id":3451,"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/posts\/3450\/revisions\/3451"}],"wp:attachment":[{"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/media?parent=3450"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/categories?post=3450"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/tags?post=3450"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}